Drawing for 28EXTREMOIN

USPTO serial 79159921

28EXTREMOIN

Reviewed by CopyMark Law Group

Reg. 4957776Status 707Renewal
Filing date
Status date
Registration date
May 17, 2016
Examiner
DELANEY, ZHALEH SYBIL
Law office
—

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with 28EXTREMOIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ROBERT S. BRODER

ROBERT S. BRODER COLLARD & ROE, P.C.1077 NORTHERN BLVD.ROSLYN, NY 11576United States

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry, in particular, for the chemical industry, the cosmetics industry, the pharmaceutical industry and the food industry; chemical reagents other than for medical or veterinary purposes; chemical additives, namely, glucosyl glycerol, ectoine and hydroxyectoine for use in further manufacture of cosmetics and pharmaceuticals; chemical preparations for stabilizing biomoleculesACTIVE—
003[ Body and beauty care cosmetics; body lotion; beauty masks; beauty soap; beauty serums; hair lotions; perfumery; dentifrices; after-sun gels; after-sun oils; anti-aging creams; anti-wrinkle creams; skin creams; non-medicated scalp treatment creams and lotions; facial creams; cosmetic preparations for skin care; non-medicated toiletries; shampoo; cosmetic sun-tanning preparations; lipsticks containing sun block; facial cleansers; soaps for personal use; fragrances; cosmetic products in the form of aerosols for skin care ]SECTION 71 - CANCELLED—
005[ Medicines for the treatment of or protection against illnesses, diseases and conditions induced by air pollution, namely, respiratory, cardiovascular, reduced immunity, increased and chronic fatigue, and eye, nose, throat and skin illnesses, diseases and conditions; astringents for medicinal purposes; medicinal drinks; pharmaceutical preparations for the treatment of or protection against illnesses, diseases and conditions induced by air pollution, namely, respiratory, cardiovascular, reduced immunity, increased and chronic fatigue, and eye, nose, throat and skin illnesses, diseases and conditions; enzymes for veterinary products; veterinary preparations for the treatment of or protection against illnesses, diseases and conditions induced by air pollution, namely, respiratory, cardiovascular, reduced immunity, increased and chronic fatigue, and eye, nose, throat and skin illnesses, diseases and conditions; food supplements for medical purposes; pharmaceutical preparations for treating mucous membranes; antiallergic medicines; antifungal preparations; germicides; chemico-pharmaceutical preparations for the treatment of or protection against illnesses, diseases and conditions induced by air pollution, namely, respiratory, cardiovascular, reduced immunity, increased and chronic fatigue, and eye, nose, throat and skin illnesses, diseases and conditions; diagnostic preparations for medical and veterinary use; dietetic sugar adapted for medical or veterinary use; vaccines; medicated mouth sprays; medicated nasal sprays; medicated throat sprays; eye drops; ocular pharmaceuticals, namely, preparations for ocular lubrication; nutritional supplements; nasal sprays for the treatment of allergies; nasal drops for the treatment of allergies; pharmaceutical skin creams; allergy tablets; pharmaceutical preparations for treating allergies; dermatological pharmaceutical products; dermatologicals; medicated creams for treating dermatological conditions; pharmaceutical preparations for treating respiratory diseases; respiratory stimulants; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for treating dry mucous membranes; pharmaceutical preparations for treating dry eyes; preparations for treating colds and related coryza, or inflammation of the mucous membranes; pharmaceutical preparations for treating neurodermatitis; sunburn preparations for pharmaceutical purposes ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 15, 2026ES71TEAS SECTION 71 RECEIVED—
May 17, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Nov 21, 2024RNWLINTERNATIONAL REGISTRATION RENEWED—
Nov 20, 2023INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Oct 16, 2023INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Oct 16, 2023INPCINVALIDATION PROCESSED—
Oct 10, 2023INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 10, 2023NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 10, 202371.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Oct 25, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 21, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 16, 2022ES71TEAS SECTION 71 RECEIVED—
May 6, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 17, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 5, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 9, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 18, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 18, 2016FIMPFINAL DISPOSITION PROCESSED—
Aug 17, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 17, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 1, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 1, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 27, 2016GPNXNOTIFICATION PROCESSED BY IB—
Feb 10, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 10, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 10, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 25, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 21, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 21, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jan 21, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 21, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 21, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 15, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 15, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 13, 2016ALIEASSIGNED TO LIE—
Jan 13, 2016ALIEASSIGNED TO LIE—
Jan 6, 2016ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 5, 2015GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 5, 2015GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 5, 2015CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 15, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 15, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 8, 2015ALIEASSIGNED TO LIE—
Jun 29, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 13, 2015RFNTREFUSAL PROCESSED BY IB—
Feb 25, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 25, 2015RFRRREFUSAL PROCESSED BY MPU—
Feb 25, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 24, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 13, 2015DOCKASSIGNED TO EXAMINER—
Feb 13, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 12, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance